Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.43 USD | +3.21% | +14.82% | 0.00% |
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | 26/21/26 | |
Nathen Fuentes
DFI | Director of Finance/CFO | 41 | 21/23/21 |
Michelle Yanez
AUD | Comptroller/Controller/Auditor | 52 | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | 26/21/26 | |
Craig Eagle
BRD | Director/Board Member | 57 | 01/22/01 |
Talhia Tuck
BRD | Director/Board Member | 46 | 01/22/01 |
Brad Kroenig
BRD | Director/Board Member | 45 | 01/22/01 |
Hugh McColl
BRD | Director/Board Member | 63 | 01/22/01 |
Michelle Yanez
AUD | Comptroller/Controller/Auditor | 52 | 01/22/01 |
Michael Jerman
BRD | Director/Board Member | 40 | 01/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,609,814 | 17,031,576 ( 57.52 %) | 0 | 57.52 % |
Company contact information
Telomir Pharmaceuticals, Inc.
855 North Wolfe Street Suite 601
21205, Baltimore
+
http://www.telomirpharma.comSector
1st Jan change | Capi. | |
---|---|---|
0.00% | 19Cr | |
+39.22% | 73TCr | |
+30.57% | 59TCr | |
-7.85% | 35TCr | |
+15.48% | 32TCr | |
-0.12% | 27TCr | |
+12.55% | 24TCr | |
+6.65% | 20TCr | |
-6.09% | 20TCr | |
-3.37% | 16TCr |
- Stock Market
- Equities
- TELO Stock
- Company Telomir Pharmaceuticals, Inc.